Paper367298
In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi.
Lopes JN and 6 others. Ann Trop Med Parasitol, 1978. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi. Papers, record 367298. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/367298
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Naphthoquinones | Major topic |
| Trypanosoma cruzi | Major topic |
| Animals | |
| Blood | |
| Chemical Phenomena | |
| Chemistry | |
| Male | |
| Methemoglobin | |
| Mice | |
| Movement | |
| Oxyhemoglobins |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41599001 | Trypanocidal Activity of Dual Redox-Active Quinones: Trypanosoma cruzi Mitochondrion as a Target Organelle In Vitro and Anti-Inflammatory Properties In Vivo. | Pathogens | 2025 | https://conductscience.org/library/papers/41599001 | PubMed |
| 33661933 | Characterization and trypanocidal activity of a β-lapachone-containing drug carrier. | PLoS One | 2021 | https://conductscience.org/library/papers/33661933 | PubMed |
| 33479619 | Synthesis of quinone imine and sulphur-containing compounds with antitumor and trypanocidal activities: redox and biological implications. | RSC Med Chem | 2020 | https://conductscience.org/library/papers/33479619 | PubMed |
| 32636724 | Molecular mechanism and health effects of 1,2-Naphtoquinone. | EXCLI J | 2020 | https://conductscience.org/library/papers/32636724 | PubMed |
| 32418003 | Synthesis of new N,S-acetal analogs derived from juglone with cytotoxic activity against Trypanossoma cruzi. | J Bioenerg Biomembr | 2020 | https://conductscience.org/library/papers/32418003 | PubMed |
| 32318101 | Antioxidant Properties of Lapachol and Its Derivatives and Their Ability to Chelate Iron (II) Cation: DFT and QTAIM Studies. | Bioinorg Chem Appl | 2020 | https://conductscience.org/library/papers/32318101 | PubMed |
| 32074167 | Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection. | Mem Inst Oswaldo Cruz | 2020 | https://conductscience.org/library/papers/32074167 | PubMed |
| 28740612 | 3-Hydroxykynurenine, a Tryptophan Metabolite Generated during the Infection, Is Active Against Trypanosoma cruzi. | ACS Med Chem Lett | 2017 | https://conductscience.org/library/papers/28740612 | PubMed |
| 28212345 | Efficient Catalytic Oxidation of 3-Arylthio- and 3-Cyclohexylthio-lapachone Derivatives to New Sulfonyl Derivatives and Evaluation of Their Antibacterial Activities. | Molecules | 2017 | https://conductscience.org/library/papers/28212345 | PubMed |
| 26200958 | ANTHELMINTIC ACTIVITY OF LAPACHOL, β-LAPACHONE AND ITS DERIVATIVES AGAINST Toxocara canis LARVAE. | Rev Inst Med Trop Sao Paulo | 2015 | https://conductscience.org/library/papers/26200958 | PubMed |
| 24465654 | A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi. | PLoS One | 2014 | https://conductscience.org/library/papers/24465654 | PubMed |
| 24376541 | Synthetic 1,4-pyran naphthoquinones are potent inhibitors of dengue virus replication. | PLoS One | 2013 | https://conductscience.org/library/papers/24376541 | PubMed |
| 24004461 | Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues. | BMC Microbiol | 2013 | https://conductscience.org/library/papers/24004461 | PubMed |
| 22091400 | Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones. | Mol Biol Int | 2011 | https://conductscience.org/library/papers/22091400 | PubMed |
| 20200474 | Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB. | Exp Mol Med | 2010 | https://conductscience.org/library/papers/20200474 | PubMed |
| 19924086 | The trypanocidal activity of naphthoquinones: a review. | Molecules | 2009 | https://conductscience.org/library/papers/19924086 | PubMed |
| 17546464 | Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone. | Parasitol Res | 2007 | https://conductscience.org/library/papers/17546464 | PubMed |
| 12937967 | Natural products as antiparasitic drugs. | Parasitol Res | 2003 | https://conductscience.org/library/papers/12937967 | PubMed |
| 2327770 | Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327770 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/367298
GET https://conductscience.org/api/papers/v1/367298/authors